Health and Human Services Secretary Robert F. Kennedy Jr., known for his public skepticism regarding vaccines, exhibited a notably subdued approach when he responded to inquiries from Congress this week.
During a session with the House Appropriations Committee on Wednesday morning, Kennedy chose not to disclose his personal views on vaccines, instead redirecting credit to the experts at the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC).
When Democratic Rep. Mark Pocan questioned whether he would vaccinate his own children against measles and chickenpox, Kennedy responded with uncertainty, saying he would “probably” choose to vaccinate against measles.
However, he stressed that his “opinions about vaccines are irrelevant” and advised that people should not seek medical guidance from him.
“I don’t want to seem like I’m being evasive, but I don’t think people should be taking advice, medical advice from me,” he stated.
He later instructed NIH Director Jay Bhattacharya to facilitate transparent communication regarding the advantages and disadvantages of vaccinations through reliable data and studies.
Kennedy’s comments signify a shift from more assertive positions he had previously embraced regarding vaccination, particularly noted during his confirmation hearings.
In those hearings, while he affirmed his support for vaccines, he stopped short of firmly stating that vaccines do not cause autism, despite substantial research dispelling that notion.
In a notable development, the HHS announced that the CDC would commence an investigation into whether vaccines could be linked to autism.
Following his remarks that he should not be considered a source of medical advice, public health experts quickly rebuked his stance.
Georges Benjamin, the executive director of the American Public Health Association, criticized Kennedy for neglecting his central responsibility to provide appropriate guidance as the nation’s chief health strategist.
“The problem is that is his job — the top line of his job description — is the nation’s chief health strategist,” Benjamin remarked during a briefing with reporters regarding Kennedy’s testimony.
Additionally, Kennedy defended the significant reductions in HHS staffing amidst concerns over whether such cuts would hinder vital health programs.
Despite the layoffs impacting approximately 10,000 workers, Kennedy maintained that he had not curtailed essential funding for life-saving research at the NIH and reiterated his commitment to safeguarding programs like Head Start, Medicare, and Medicaid.
His claims, however, were met with skepticism by Democratic Rep. Rosa DeLauro, who pressed him for assurance that he would not eliminate congressionally approved and funded initiatives.
“You do not have the authority to do what you are doing,” DeLauro admonished, referencing the $20 billion in cuts to NIH and other program reductions.
The repercussions of these cuts, according to DeLauro, could be dire, stating bluntly, “Because of these cuts people will die.”
The hearings saw Kennedy rebut criticism regarding the HHS’s handling of recent measles outbreaks in the U.S.
He asserted, “We are doing a better job at CDC today than any nation in the world controlling this measles outbreak,” defending his agency’s actions and decisions.
In response, DeLauro challenged Kennedy’s assertions, questioning the validity of comparing the U.S. measles management to that of other nations.
According to her, Kennedy’s references did not accurately reflect comparisons with countries in Western Europe, which have reportedly had more successful outcomes in managing measles incidences without resulting in fatalities.
Kennedy also found himself under fire regarding his remarks on fluoride.
During a conversation with Republican Rep. Mike Simpson, a practicing dentist, concerns arose over Kennedy’s previous claims about fluoride in drinking water affecting children’s neurological development.
Simpson pointedly noted his professional experiences supporting fluoride’s benefits in cavity prevention, highlighting a disconnect with Kennedy’s proposed task force aimed at altering CDC recommendations on fluoride use.
He expressed a desire to critically evaluate the scientific basis for Kennedy’s approach, emphasizing, “I want to see the studies on this and where we’re headed with this.”
Previous analyses by public health authorities have typically upheld the safety and efficacy of fluoride in promoting dental health without serious health risks.
As Kennedy prepares for continued testimony, including an expected appearance before the Senate Health, Education, Labor, and Pensions Committee later that day, the pressures of his dual roles as a public health leader and a controversial figure remain at the forefront of national discourse.
With ongoing protests during his hearings, compounded by dissenting opinions from health advocates, the current environment at HHS continues to evolve amid contentious scrutiny.
image source from：https://abcnews.go.com/Health/rfk-jr-testify-house-senate-committees-amid-layoffs/story?id=121771047
